Company Overview
Aereus Technologies Ltd., based in Ontario, Canada, is a pioneering biotechnology company specializing in innovative, antimicrobial copper-based solutions designed to combat bacterial infections. Founded in 2009, with headquarters located in Rosemont, the company has consistently advanced eco-friendly infection control technologies such as the CuVerro Shield™, a product registered with both the EPA and PMRA.
In addition, Aereus owns Interspec Systems Ltd., a company that manufactures hospital headwalls and accessories, further expanding its healthcare sector footprint.
Industry and Market Position
Aereus Technologies is prominently positioned within the Specialty Chemicals sector, operating broadly under biotechnology research. The company is recognized as a leader in the development of sustainable copper-based antimicrobial products that can be applied across various surfaces, positively impacting health and safety on a global scale. This positions Aereus as a notable player in antimicrobial coatings, particularly in the health care and public safety industries.
Key Executives
- Tom Portman: Chief Executive Officer and Chief Technology Officer, instrumental in technological leadership since the company's inception.
- John Baxter: President and Chief Operating Officer, focusing on strengthening the company's core competencies.
- Ryan Peyman: Chief Financial Officer, with financial expertise from the University of Toronto's Rotman School of Management.
- Bryan Reichard: Vice President of Operations, known for his strategic role in enhancing product delivery and efficiency.
- Terry Frank: Executive Vice President of Sales & Marketing, responsible for expanding market reach and solidifying customer relationships.
- Scot Robinson: Production Manager, playing a key role in managing production processes.
Recent Developments
In 2022, Aereus Technologies launched an e-commerce platform to streamline the purchase of their innovative copper products, reflecting their strategic focus on digital transformation and expanding market accessibility.
Financial Overview
Aereus Technologies reports an estimated annual revenue of $2 million with a stable workforce of 13 employees, suggesting a revenue per employee approximation of $155,000.
Competitive Landscape
Aereus Technologies operates within the biotechnology and antimicrobial technology sectors, facing competition from various companies with different market sizes and focuses, including:
1. Tetra Bio-Pharma: $0.7M revenue, 9 employees
2. Cyclica: $0.9M revenue, 11 employees
3. Semex: $87.6M revenue, 565 employees
4. TREVENTIS Corporation: $2.8M revenue, 18 employees
5. Spartan Bioscience: $7.8M revenue, 50 employees
These competitors vary in their scope, ranging from biotech drug discovery to genetic and health-related solutions.
Market Position and Strategy
Aereus Technologies has established a niche as a leader in antimicrobial copper solutions, particularly relevant to healthcare and public health sectors. With ownership of Interspec Systems Ltd., Aereus enhances its synergy between antimicrobial technology and healthcare manufacturing capabilities. The company's focused approach on microbial safety, healthcare applications, and leveraging proprietary antimicrobial solutions aims at driving growth and expanding market applications in sectors where pathogen control is critical.
Contact Information
- Address: 995841 Mono/Adjala Townline Rr#1, Rosemont, Ontario, L0N 1R0, Canada
- Website: [Aereus Technologies](https://aereustech.com/)
- Social Media: Active on Facebook, Twitter, and LinkedIn for updates on products, research, and industry developments.
Strategic Goals and Vision
Aereus Technologies is committed to innovation within the biotechnology industry, focusing on expanding their copper-based product catalog aimed at enhancing public health. Their strategic goals include increasing product efficacy and market presence through innovative solutions and strategic partnerships. Aereus's dedication to researching and developing antimicrobial technologies reiterates their commitment to contributing to a sustainable and safer environment, highlighting their potential for expanded application and market outreach in hygiene-critical environments.
